Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 9/20 | 0.31 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27879310 | 0.98 | TSHR (0.46) | TSHRALDH1A1THRBFDPSGGPS1 | |
| SCHEMBL9585050 | 0.98 | TSHR (0.46) | TSHRALDH1A1THRBFDPSGGPS1 | |
| SCHEMBL4733861 | 0.98 | TSHR (0.46) | TSHRALDH1A1THRBFDPSGGPS1 | |
| Hydrochloric Acid SCHEMBL28154624 | 0.94 | TSHR (0.43) | TSHRALDH1A1THRBFDPSGGPS1 | |
| SCHEMBL11597720 | 0.93 | TSHR (0.42) | TSHRALDH1A1 | |
| SCHEMBL9056413 | 0.84 | TSHR (0.35) | TSHR | |
| SCHEMBL3292585 | 0.82 | — | — | |
| SCHEMBL11093025 | 0.82 | TSHR (0.39) | TSHRALDH1A1FDPSGGPS1FAAH | |
| SCHEMBL8960454 | 0.81 | — | — | |
| SCHEMBL3669175 | 0.81 | TSHR (0.42) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE31812-E | TO ALDEHYDES IN PRESENCE OF CATALYTIC SYSTEM CONTAINING RHODIUM AND SULFONATED ARYL PHOSPHINE COMPOUND | RHONE-POULENC INDUSTRIES (FR) | 1985-01-22 | — | — | US | claimed |
| US-4248802-A | Catalytic hydroformylation of olefins | RHONE-POULENC INDUSTRIES (FR) | 1981-02-03 | — | — | US | claimed |
| US-12006282-B2 | Continuous hydroformylation process with catalyst substitution | OQ CHEMICALS GMBH (DE) | 2024-06-11 | — | — | US | disclosed |
| EP-3770144-B1 | CONTINUOUS HYDROFORMYLATION PROCESS WITH CATALYST SUBSTITUTION | OQ CHEMICALS GMBH (DE) | 2023-09-06 | — | — | EP | disclosed |
| EP-4112599-A1 | KEY INTERMEDIATE FOR SYNTHESIZING PROSTAGLANDIN COMPOUNDS AND PREPARATION METHOD THEREFOR | SHENZHEN CATALYS TECHNOLOGY CO., LTD. (CN) | 2023-01-04 | — | — | EP | disclosed |
| US-20220371979-A1 | Continuous Hydroformylation Process With Catalyst Substitution | OQ CHEMICALS GMBH (DE) | 2022-11-24 | — | — | US | disclosed |
| WO-2021013848-A1 | CONTINUOUS HYDROFORMYLATION PROCESS WITH CATALYST SUBSTITUTION | OQ CHEMICALS GMBH (DE) | 2021-01-28 | — | — | WO | disclosed |
| EP-3770144-A1 | CONTINUOUS HYDROFORMYLATION PROCESS WITH CATALYST SUBSTITUTION | OQ Chemicals GmbH (DE) | 2021-01-27 | — | — | EP | disclosed |
| WO-2017017146-A1 | COMPOSITIONS CONTAINING POLYANION, ETHOXYLATED CATIONIC POLYMER AND PHYLLOSILICATES FOR IMPROVED OXYGEN BARRIER COATINGS | BASF SE (DE) | 2017-02-02 | — | — | WO | disclosed |
| US-9272986-B2 | Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex | INTREXON CORPORATION (US) | 2016-03-01 | — | — | US | disclosed |
| US-20150005256-A1 | Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes in Mammalian Systems via an Ecdysone Receptor Complex | INTREXON CORP (US) | 2015-01-01 | — | — | US | disclosed |
| CN-85105099-A | The method for preparing aldehyde | — | 1986-12-31 | — | — | CN | disclosed |
| US-4593126-A | Reacting an olefin with carbon monoxide and hydrogen | RUHRCHEMIE AKTIENGESELLSCHAFT (DE) | 1986-06-03 | — | — | US | disclosed |
| EP-0160249-A2 | Process for the preparation of aldehydes | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-11-06 | — | — | EP | disclosed |
| EP-0158246-A2 | Process for the production of aldehydes | Ruhrchemie Aktiengesellschaft (DE) | 1985-10-16 | — | — | EP | disclosed |
| EP-0149894-A2 | Hydroformylation process | DAVY McKEE (LONDON) LIMITED (GB) | 1985-07-31 | — | — | EP | disclosed |
| US-RE31812-E | TO ALDEHYDES IN PRESENCE OF CATALYTIC SYSTEM CONTAINING RHODIUM AND SULFONATED ARYL PHOSPHINE COMPOUND | RHONE-POULENC INDUSTRIES (FR) | 1985-01-22 | — | — | US | disclosed |
| EP-0096987-A2 | Hydroformylation process | DAVY McKEE (LONDON) LIMITED (GB) | 1983-12-28 | — | — | EP | disclosed |
| EP-0096986-A2 | Hydroformylation process | DAVY McKEE (LONDON) LIMITED (GB) | 1983-12-28 | — | — | EP | disclosed |
| US-4248802-A | Catalytic hydroformylation of olefins | RHONE-POULENC INDUSTRIES (FR) | 1981-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220371979-A1 | Continuous Hydroformylation Process With Catalyst Substitution | CYP4F3, CYP4F2, CYP2F1 | TSHR 1960/4885ALDH1A1 2642/4885THRB 876/4885 |
| US-12006282-B2 | Continuous hydroformylation process with catalyst substitution | CYP4F3, CYP4F2, CYP2F1 | TSHR 1960/4885ALDH1A1 2642/4885THRB 876/4885 |
| US-20150005256-A1 | Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes in Mammalian Systems via an Ecdysone Receptor Complex | NR2E3, NR2C2, NR5A2 | TSHR 547/4885ALDH1A1 3743/4885THRB 245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.